Lawton Alison Frances 4
4 · Dianthus Therapeutics, Inc. /DE/ · Filed May 28, 2024
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-23+11,000→ 11,000 totalExercise: $21.77Exp: 2034-05-22→ Common Stock (11,000 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date.